Antisense Therapeutics Limited Stock Technical Analysis

ATHJF Stock  USD 0.04  0.00  0.00%   
As of the 2nd of December, Antisense Therapeutics shows the Standard Deviation of 39.12, risk adjusted performance of 0.0993, and Mean Deviation of 9.72. Antisense Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Antisense Therapeutics standard deviation, as well as the relationship between the treynor ratio and kurtosis to decide if Antisense Therapeutics is priced correctly, providing market reflects its regular price of 0.042 per share. As Antisense Therapeutics appears to be a penny stock we also recommend to validate its information ratio numbers.

Antisense Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Antisense, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Antisense
  
Antisense Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Antisense Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Antisense Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Antisense Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Antisense Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Antisense Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Antisense Therapeutics Trend Analysis

Use this graph to draw trend lines for Antisense Therapeutics Limited. You can use it to identify possible trend reversals for Antisense Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Antisense Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Antisense Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Antisense Therapeutics Limited applied against its price change over selected period. The best fit line has a slop of   0.0003  , which means Antisense Therapeutics Limited will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.0, which is the sum of squared deviations for the predicted Antisense Therapeutics price change compared to its average price change.

About Antisense Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Antisense Therapeutics Limited on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Antisense Therapeutics Limited based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Antisense Therapeutics price pattern first instead of the macroeconomic environment surrounding Antisense Therapeutics. By analyzing Antisense Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Antisense Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Antisense Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.

Antisense Therapeutics December 2, 2024 Technical Indicators

Most technical analysis of Antisense help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Antisense from various momentum indicators to cycle indicators. When you analyze Antisense charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Complementary Tools for Antisense Pink Sheet analysis

When running Antisense Therapeutics' price analysis, check to measure Antisense Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Antisense Therapeutics is operating at the current time. Most of Antisense Therapeutics' value examination focuses on studying past and present price action to predict the probability of Antisense Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Antisense Therapeutics' price. Additionally, you may evaluate how the addition of Antisense Therapeutics to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency